As a clinician, investigator and director of the Vaccine Evaluation Center (VEC) at BC Children’s Hospital, Sauder Family Chair in Pediatric Infectious Diseases and Associate Professor at the University of British Columbia, Dr. Manish Sadarangani has become even busier since the start of the COVID-19 pandemic. To help recognize National Immunization Awareness Month, he answered…
Hydroxyzine is a first-generation antihistamine commonly prescribed in syrup form to infants and young children with itch-inducing skin conditions, such as atopic dermatitis and eczema. New research shows that the more hydroxyzine a child is prescribed, the higher their risk for developing a tic, anxiety, or conduct disorder.
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) and Women’s Health Research Institute (WHRI) investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Spring 2022 Project Grant competition. Our research community received around $15 million in new research grants as principal investigators or co-investigators.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.